Dysregulation of CD4+and CD8+resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.507. It has been cited 15 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.0909
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
Burroughs Wellcome Fund
Grant: Career Award for Medical Scientists
National Institutes of Health
Grant: K08AI139375
Kenneth Rainin Foundation
Grant: KRA000152
NCI NIH HHS
Grant: R35 CA253175
Crohn’s and Colitis Foundation
Grant: Career Development Award
UCSF ImmunoX
Grant: CoPilot Award
V Foundation for Cancer Research
Grant: T2023-011
Damon Runyon Cancer Research Foundation
Grant: CI 110-21
Parker Institute for Cancer Immunotherapy
Grant: N/A
NIDDK NIH HHS
Grant: K08 DK123202
National Institutes of Health
Grant: 5R35CA253175-03
Determinants of response to cancer immunotherapy
National Institutes of Health
Grant: 5K08AI139375-04
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events
National Institutes of Health
Grant: 1K08DK123202-01
Mechanisms of intestinal epithelial injury in intestinal inflammation
FWCI
2.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals